California Stem Cell Meeting: CIRM Directors Decide to Press Harder on Therapy Development
Directors of the California stem cell agency today voted to intensify their focus on a handful of projects most likely to advance through clinical trials despite concerns that other efforts by the agency could suffer as a result.
On a unanimous roll call vote, the board approved a motion to create a priority system as recommended by its new Scientific Ad…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.